Search
for
Sort by
Research 30 of 98
- Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Cutaneous Toxicities of Advanced Treatment for Cutaneous Melanoma: A Prospective Study from a Single-Center Institution
- Risk of Autoimmune Skin Diseases Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis Using the FAERS Database
- Cemiplimab-Induced Alopecia Areata
- ODP342 Panhypopituitarism Induced by CTLA-4 and PD-1/PD-L1 Inhibitor Immunotherapy
- Tombo em João Pessoa dá força a Memorial da Arquitetura Paraibana
- A bibliometric study of the top 100 most cited articles on melanoma: insights into research trends and characteristics
- Biological therapy in the treatment of melanoma
- Decreased benzothiazole-type pheomelanin in regrown brown hair in alopecia areata
- Cutaneous toxicities of new treatments for melanoma
- The Influence of Flightless I: Regeneration versus Wound Healing
- 15460 Perifollicular pink halo: A potential dermoscopic marker of inflammation in central centrifugal cicatricial alopecia
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Hair disorders in patients with cancer
- Alopecia in patients treated with molecularly targeted anticancer therapies
- Drug Repurposing - Hypothesis, Molecular Aspects and Therapeutic Applications
- iNKT cells ameliorate human autoimmunity: Lessons from alopecia areata
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Alopecia in Association with Malignancy: A Review
- A comparative analysis of immune privilege in pregnancy and cancer in the context of checkpoint blockade immunotherapy
- Exosomes as a novel pathway for regulating development and diseases of the skin (Review)
- Dermatologic Reactions to Targeted Therapy
- Cutaneous Reactions to Drugs
- Cancer Treatments and Alopecia: A Systematic Review
- Dermatologic Adverse Events from Cancer Treatments
- Management of Toxicities of Targeted Therapies